Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular Edema

Saved in:
Bibliographic Details
Published inJAMA ophthalmology Vol. 135; no. 3; p. 291
Main Authors Clark, W Lloyd, Boyer, David S, Kaiser, Peter K
Format Journal Article
LanguageEnglish
Published United States 01.03.2017
Subjects
Angiogenesis Inhibitors
Bevacizumab
Diabetic Retinopathy
Humans
Intravitreal Injections
Macular Edema
Off-Label Use
Tomography, Optical Coherence
Vascular Endothelial Growth Factor A
Online AccessGet more information

Cover

Be the first to leave a comment!
You must be logged in first